-

Quantori MLConfGen Wins “Machine Learning Innovation Award” in 2026 AI Breakthrough Awards Program

Ninth Annual Program Honors the AI Innovators Shaping the Next Era of Global Innovation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, today announced that its MLConformerGenerator solution has been selected as the winner of the “Machine Learning Innovation Award” in the 9th annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market today.

With MLConfGen, researchers can design new, synthesizable, and valid molecular structures, opening up exciting opportunities in drug discovery at scale.

Share

MLConformerGenerator is an inference server for spatially aware, objective-driven AI-assisted molecular design available on AWS and Google Cloud marketplaces. It enables the generation of novel molecular structures tailored to specific shapes and binding sites, supporting advanced drug discovery and precision molecular engineering workflows. Its core capabilities include shape-guided molecular generation for protein binding pockets and arbitrary 3D constraints, objective-driven optimization using reinforcement learning with custom scoring functions, reference-based conformer similarity for scaffold hopping and ligand-based design, and fragment-based generation for controlled molecule editing and growth.

“With MLConfGen, researchers can design new, synthesizable, and valid molecular structures tailored to specific shapes, opening up exciting opportunities in drug discovery and molecular design at scale,” said Richard Golob, CEO of Quantori. “We believe AI holds the key to helping biopharma innovators accelerate R&D pipelines and bring transformative therapies to patients across the globe. Our AI-driven solutions are empowering innovation in the life sciences and healthcare industries.”

For nearly a decade, the AI Breakthrough Awards have researched, analyzed and recognized the most important advances in artificial intelligence, and this year's field is the strongest yet. Thousands of nominations from over 20 countries poured in across categories including Agentic AI, Generative AI, Computer Vision, AIOps, Robotics, Natural Language Processing and industry-specific AI applications – underscoring the explosive global growth of AI and its importance as the defining technology of our time.

“MLConformerGenerator achieves huge improvements over standard enumeration while lowering computational overhead. Molecular generation has evolved toward more constraint aware forms of molecular design, giving rise to pocket-aware and profile-aware systems with more expressive power. However, that expressivity can increase setup complexity, computational overhead, and resource demands,” said Steve Johansson, managing director, AI Breakthrough. “Whether you are building the next-generation therapeutic or exploring chemical space, MLConformerGenerator provides a scalable, shape-aware solution for molecular generation.”

About Quantori

Quantori is a digital transformation and technology solutions company accelerating the digitization of life sciences and healthcare. Quantori transforms complex data into business value by combining deep industry knowledge, engineering excellence, and applied AI. Quantori's Q-Suite platform provides modular software accelerators that enable rapid development of cloud-native scientific systems integrating machine learning, high-performance computing, and experimental data pipelines. Learn more at quantori.com and keep connected on social media X, LinkedIn, and Facebook.

About AI Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the AI Breakthrough Awards program is devoted to honoring excellence in Artificial Intelligence technologies, services, companies and products. The AI Breakthrough Awards provide public recognition for the achievements of AI companies and products in categories including Agentic AI, Machine Learning, Generative AI, Robotics, AI Hardware, Computer Vision and more. For more information visit AIBreakthroughAwards.com.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Contacts

Media Contact
Quantori:
Elizaveta Agafonova
Senior Marketing Manager
Email: elizaveta.agafonova@quantori.com

Quantori

Details
Headquarters: Cambridge, Massachusetts
CEO: Richard Golob
Employees: 500
Organization: PRI

Release Summary
Quantori's MLConfGen wins the Machine Learning Innovation Award at the 2026 AI Breakthrough Awards for advancing AI-assisted molecular design.
Release Versions

Contacts

Media Contact
Quantori:
Elizaveta Agafonova
Senior Marketing Manager
Email: elizaveta.agafonova@quantori.com

Social Media Profiles
More News From Quantori

Quantori and Knowledge3 Announce Co-Marketing Partnership to Advance Knowledge-Driven AI in Life Sciences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, today announced a co-marketing partnership with Knowledge3 (K3), a company focused on bridging the gap between business goals and IT delivery through Knowledge Graphs, FAIR data principles, and graph-grounded Generative AI. The partnership brings together Quantori’s expertise in AI, scientific software engineering, and life sciences R...

ImmuVia Selects Quantori’s Q-Scientist Platform to Accelerate Development of First-in-Class Cancer Therapy

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuVia Inc., a biotechnology company developing first-in-class therapies for solid tumors, today announced that it has selected Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, as a strategic technology partner. ImmuVia will deploy Quantori’s Q-Scientist platform to streamline computational workflows across its preclinical programs, with the goal of compressing development timeline...

Quantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI Models

CAMBRIDGE, Mass. & SAN DIEGO--(BUSINESS WIRE)--Quantori and Expert Systems partner to integrate foundational predictive AI models into Q-Scientist, accelerating smarter, faster drug discovery....
Back to Newsroom